Summit team led by Dr. The CEO of Pulsus Group, Srinubabu Gedela, recently gave a roadshow at the 72nd Indian Pharmaceutical Congress (IPC) in Nagpur to formulate policies on his digital transformation into biopharmaceuticals.
The event brought together 50 influential policymakers, global pharmaceutical experts, and other decision-makers to bring the Global Tech Summit to life in drug discovery, and regulatory affairs, and make it more affordable for all. We discussed how to become an innovative platform for applying cutting-edge technology to price medicines.
At the Biopharma Digital Transformation Policy Deliberations roundtable series, attendees heard from key industry figures about the challenges facing regulators in digital healthcare.
Dr. Dominique Jordan, President of the International Federation of Pharmaceutical Sciences, highlighted the potential impact of this technology on innovative drug discovery. “Digital transformation in the pharmaceutical industry involves implementing various digital technologies to improve the production and delivery of healthcare products and services.
“Digital transformation can benefit the pharmaceutical industry in a variety of ways, including improved drug development, patient care, and interaction; technology helps to make medicine more affordable and accessible; it reduces carbon footprint; and it improves supply chain transparency.”
The Global Tech Summit team and experts in attendance also discussed the importance of using digital technologies in drug discovery, such as Artificial Intelligence (AI) and Machine Learning (ML). Dr. Atul Nasa, former Controlling Licensure Authority, and current President of, the Indian Pharma Graduates Association, said, “AI and ML can help accelerate drug discovery by analyzing large amounts of data and identifying potential drug candidates quickly and efficiently.”
“Regulators must find a balance between encouraging innovation and protecting public health,” said Dr. HG Khosla, Commissioner, of the Food and Drug Control Administration (FDCA), Government of Gujarat. Dr. Montukumar M Patel, the President, of the Pharmacy Council of India(PCI), also spoke at the meeting about some of the challenges facing regulators when it comes to digital healthcare.
Abhijit Ghosh, Assistant Drug Controller, Medical Device Standards Control Organization, provided his expert opinion on the potential way forward for India. “Digital transformation in the pharmaceutical industry is inevitable, and India should take the lead in developing policies that encourage innovation while protecting public health.”
Dr. T V Narayana, President of, the Indian Pharmaceutical Association, and Dr. Alka Mukne, Editor-in-Chief, of Pharma Times, emphasized the importance of collaboration between the pharma and academic industry, stating that combining the financial backing of pharma companies with early-stage drug molecules from academic institutions is a key source of innovation, with many successful assets being developed and commercialized through institutional technology out-licensing. Dr. NASA also expressed its support for making Global Tech Summit 2023 a platform for digital transformation in the pharmaceutical industry.
Global Tech Summit
Posted on: Feb 13, 2023
